Benzinga | Aug 17, 2021 07:13AM EDT

SVB Leerink Initiates Coverage On Caribou Biosciences with Outperform Rating, Announces Price Target of $32

SVB Leerink analyst Mani Foroohar initiates coverage on Caribou Biosciences (NASDAQ:CRBU) with a Outperform rating and announces Price Target of $32.